Travere Therapeutics
TVTX
TVTX
177 hedge funds and large institutions have $1.16B invested in Travere Therapeutics in 2024 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 62 increasing their positions, 58 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
7% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 58
7.45% less ownership
Funds ownership: 115.62% → 108.16% (-7.5%)
17% less call options, than puts
Call options by funds: $12.4M | Put options by funds: $14.9M
Holders
177
Holding in Top 10
3
Calls
$12.4M
Puts
$14.9M
Top Buyers
| 1 | +$42.9M | |
| 2 | +$18M | |
| 3 | +$15.4M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$15.3M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$10.5M |
Top Sellers
| 1 | -$95.7M | |
| 2 | -$39.7M | |
| 3 | -$29.9M | |
| 4 |
TF
Talbot Financial
Bellevue,
Washington
|
-$12.9M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$11.7M |